T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Microchip Technology
MCHP
$42.8B
| $53.6M | 0.01% |
829,417
-530,443
| -39% | -$38.2M |
|
752
Frontdoor
FTDR
$5.02B
| $53.6M | 0.01% |
1,013,507
-557,161
| -35% | -$33.2M |
|
|
SGI
753
Somnigroup International
SGI
$15.1B
| $53.4M | 0.01% |
722,924
+357
| +0% | +$31K |
|
754
Apple Hospitality REIT
APLE
$3.96B
| $53.3M | 0.01% |
4,634,156
-951,670
| -17% | -$11.5M |
|
755
Strategy Inc
MSTR
$33.5B
| $53.2M | 0.01% |
426,155
+18,586
| +5% | +$2.66M |
|
756
D.R. Horton
DHI
$41B
| $53M | 0.01% |
386,503
-21,398
| -5% | -$3.23M |
|
757
AXT Inc
AXTI
$3.09B
| $51.8M | 0.01% |
+909,753
| New | +$30.2M |
|
758
Globus Medical
GMED
$10.4B
| $51.7M | 0.01% |
600,165
-95,794
| -14% | -$8.6M |
|
759
Compass
COMP
$8.27B
| $51.6M | 0.01% |
7,055,229
-2,307,139
| -25% | -$24.2M |
|
760
Abercrombie & Fitch
ANF
$4.17B
| $51.4M | 0.01% |
562,590
+7,774
| +1% | +$756K |
|
761
Customers Bancorp
CUBI
$2.59B
| $51.2M | 0.01% |
737,884
-133,712
| -15% | -$9.72M |
|
762
Hewlett Packard
HPE
$63.2B
| $51.1M | 0.01% |
2,147,730
+247,566
| +13% | +$5.49M |
|
763
Kadant
KAI
$3.69B
| $51.1M | 0.01% |
174,846
-16,105
| -8% | -$5.17M |
|
764
Nurix Therapeutics
NRIX
$2.43B
| $51M | 0.01% |
3,290,233
+41,872
| +1% | +$694K |
|
765
Affiliated Managers Group
AMG
$9.46B
| $50.8M | 0.01% |
183,621
-58,671
| -24% | -$17.7M |
|
766
Brink's
BCO
$5.02B
| $50.6M | 0.01% |
488,310
+5,896
| +1% | +$707K |
|
|
PVLA
767
Palvella Therapeutics
PVLA
$1.98B
| $50.2M | 0.01% |
402,564
+398,474
| +9,743% | +$41.6M |
|
768
Argan
AGX
$7.98B
| $50M | 0.01% |
91,866
+35,211
| +62% | +$14.4M |
|
769
Aehr Test Systems
AEHR
$2.48B
| $50M | 0.01% |
1,349,351
+1,314,967
| +3,824% | +$42.1M |
|
770
Ocular Therapeutix
OCUL
$1.86B
| $50M | 0.01% |
5,897,149
+5,725,625
| +3,338% | +$54.6M |
|
771
Boyd Gaming
BYD
$6.47B
| $49.5M | 0.01% |
601,725
-7,115
| -1% | -$597K |
|
772
Arch Capital
ACGL
$36.1B
| $49.3M | 0.01% |
513,948
-10,306
| -2% | -$987K |
|
773
Coca-Cola Consolidated
COKE
$12.3B
| $49.1M | 0.01% |
256,144
+6,158
| +2% | +$1.08M |
|
774
Ambarella
AMBA
$2.99B
| $49M | 0.01% |
952,315
+87,705
| +10% | +$5.47M |
|
775
Itron
ITRI
$3.73B
| $48.8M | 0.01% |
544,444
-63,497
| -10% | -$6.1M |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.